Vodafone Idea Limited FPO...
26 Aug, 2025
Amanta Healthcare Ltd IPO
Amanta Healthcare IPO opens on September 1, 2025 and closes on September 3, 2025, at ₹120–₹126 per equity share with a face value of ₹10. The company is looking to raise ₹126 crore (approx) via a 100% fresh issue of 1.00 crore equity shares of ₹10 face value and there is no offer for sale. The lot size is 119 shares per application and category allocation of 50 percent for QIB, 15 percent for NII and 35 percent for retail for the net issue. As per the tentative schedule of the issue, the basis of allotment will be on September 4, refunds and credit to the account on September 5 and listing on BSE and NSE on September 8, 2025. Beeline Capital Advisors is the book-running lead manager and MUFG Intime India is the registrar of the IPO.
Company Background
Amanta Healthcare IPO is a manufacturer that is focused on sterile liquid products, particularly LVPs and SVPs, made on Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blowing Moulding (ISBM) lines. The Company had a total of seven parenteral lines (four Large Volume parenterals and 3 small volume parenterals) at a WHO-GMP certified unit having 66,852 sq. meters at Hariyala, District Kheda, State of Gujarat as of 31 December 2024. The sales for FY25 came in at ₹276.09 crore and profit after tax at ₹10.5 crore – indicating a strong improvement in performance on a YoY basis, while key to that has been a broader execution push.
Operations & Product Range
Amanta manufactures more than 45 generics for six categories, from fluid therapy, ophthalmics, respiratory care, irrigation solutions, to other related sterile solutions in container volumes ranging from 2 ml up to 1000 ml and closure options. It has 1,727 employees (including 509 full-time employees) and has exclusive F&D space and quality control laboratories manned by 128 professionals, which depicts the emphasis on sterile production controls. Its commercial footprint includes domestic and export businesses with regulatory filings and product registrations to ensure market access and security of supply.
Facility & Production
The manufacturing facility of Amanta Healthcare IPO is located in Hariyala, Kheda WHO-GMP certified plant, where it has 4 LVP Lines and 3 SVP Lines for Aseptic liquid filling technology with the help of ABFS and ISBM. The features are suitable for multiple fill volumes and closure systems while providing the required therapy breadth and packaging flexibility for hospital and retail channels. In-house F&D, QC and QA teams are further strength to production’s bottom which is charged with Process validation, sterility assurance & batch release requirements for sterile injectables.
Brands & Market Presence
Amanta caters to hospitals, trade channels and collaborated pharmaceutical companies all over India with presence across 316 stockists supported with 108 field personnel for domestic coverage. The company's global footprint is reported in 19 unique countries across 112 jurisdictions and 47 products registered, indicating a focus on regulatory filings and dossier-based market entry. Apart from own-label supplies, Amanta associates with Indian and multinational pharma companies for commercial-line and license-based deals, thus providing increased visibility and recurring business.
Revenue Channels
- Sale of LVPs and SVPs (e.g., fluid therapy, ophthalmic, respiratory, irrigation solutions) to hospitals, institutions and trade networks in India.
- Exports of sterile liquid products into 19 countries through product registrations covering 112 jurisdictions.
- Contract manufacturing and license-based commercial supply partnerships with Indian and global pharmaceutical companies.
Management & Shareholding
Amanta Healthcare IPO management is promoter-driven with the help of heads of manufacturing, quality, regulatory, finance and sales to run sterile operations at scale. Credit metrics are expected to improve through FY24 with leverage and coverage ratios and sufficient liquidity and a stable working capital cycle, in line with additional growth investments ahead of capacity additions.
Promoters & shareholding
The promoters of Amanta Healthcare IPO are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendrakumar Patel and Milcent Appliances Private Limited, who are holding the management leash by having significant control over the strategic and operational functions. The IPO is a fresh issue of 1.00 crore shares that would lead to a dilution of promoter holding in line with the capitalisation of the company and will keep promoter anchor investors' interest in strategic decisions after listing.
Board Members
The board of Amanta Healthcare IPO is a mix of promoter directors & professional management and it is expected to have committees for audit, nomination & remuneration and stakeholder relations as per the mainboard governance requirements.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Amanta Healthcare Ltd IPO
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Amanta Healthcare Ltd IPO Details
| Detail | Description |
|---|---|
| IPO Date | September 1, 2025 to September 3, 2025 |
| Listing Date | - |
| Face Value | ₹10 per share |
| Issue Price Band | ₹120 to ₹126 per share |
| Lot Size | 119 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,00,00,000 shares (aggregating up to ₹126.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,88,29,351 shares |
| Share Holding Post Issue | 3,88,29,351 shares |
Amanta Healthcare Ltd IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Mon, Sep 1, 2025 |
| IPO Close Date | Wed, Sep 3, 2025 |
| Tentative Allotment | Thu, Sep 4, 2025 |
| Initiation of Refunds | Mon, Sep 8, 2025 |
| Credit of Shares to Demat | Mon, Sep 8, 2025 |
| Tentative Listing Date | Tue, Sep 9, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 3, 2025 |
Amanta Healthcare Ltd IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Amanta Healthcare Ltd IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Share Holding Pre Issue | 85.60% |
| Share Holding Post Issue | 63.56% |
Competitive Strength:
- ● Focused sterile liquid platform with seven parenteral lines (4 LVP, 3 SVP) operating within a WHO-GMP certified facility at Hariyala, Gujarat.
- ● Technology based on ABFS and ISBM for sterile filling of multi-volume formats (2ml to 1000ml) and closures for 45+ products.
- ● Domestically widespread presence with 316+ stockists and a 108-strong sales team, in addition to 19 export markets covering 112 jurisdictions.
- ● Partnership-based model with Indian and MNC pharma companies for contract manufacturing & license-based supply and to promote use and recurring revenues.
Amanta Healthcare Ltd IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 381.76 | 276.09 | 10.5 | 96.39 | 195 | |||||||||||||||||||||||||||||||||||
| 31 Mar 2024 | 352 | 282 | 4 | 66 | 205.23 | |||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 374.06 | 262.7 | -2.11 | 62.88 | 215.66 | |||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.64 | 3 |
| P/E (x) | 34.59 | 47 |
Objectives of Amanta Healthcare IPO
- Capex of ₹70 cr to set up a new manufacturing line of SteriPort to enhance sterile capacity and product width.
- A Capex of ₹30.13 crore toward building and equipment for a new SVP line to increase capacity and SKU flexibility.
- Balance for general corporate purposes, including systems, talent and operating resilience during scale-up.
Conclusion
The Amanta Healthcare IPO is expected to raise about ₹126 crore at a price band of ₹120-126 per share through 100% FII, which will be invested in setting up new sterile capacity in SteriPort and SVP lines. The company’s WHO-GMP-validated plant, seven-line sterile platform and mix of own-label and partnered supply across India and export markets leave it well-positioned to compound volumes as new lines come online. For investors following healthcare manufacturing, sterile capabilities, track record of registrations and growth capex provide an easy-to-follow roadmap to hitting the FY26 targets.
RHP:
DRHP:
Read more :
Frequently asked Questions (FAQs )
-
● What are the Amanta Healthcare IPO dates?
The IPO opens on September 1, 2025 and closes on September 3, 2025.
-
● How much is being raised and what is the issue type?
About ₹126 crore via a 100% fresh issue of 1.00 crore equity shares; there is no OFS.
-
● What is the lot size of the Amanta Healthcare IPO?
The lot size is 119 shares per application.
-
● What does Amanta Healthcare make?
Sterile liquid products, including IV fluids, ophthalmic solutions, respiratory care products, diluents and irrigation solutions made using ABFS and ISBM.
.jpg)
